Expression of Molecular Markers Before and After Neo-adjuvant Chemoradiotherapy in Rectal Cancer

Withdrawn

• Conditions: Rectal Cancer

• Registration Number: NCT00835055
• Lead Sponsor: St. Claraspital AG

Brief Summary

The purpose of this study is to determine whether markers on tumor tissue may be an indicator for good response to neoadjuvant chemoradiotherapy in patients with rectal cancer.

Detailed Description

Not available

Study Timeline

• Study Start: 2005-04
• Study First Submitted: 2009-02-02
• Study First Submitted QC: 2009-02-02
• Study First Posted: 2009-02-03
• Status Verified: 2019-04
• Primary Completion: 2019-04-01
• Study Completion: 2019-04-01
• Last Update Submitted: 2019-04-03
• Last Update Posted: 2019-04-05

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• locally advanced rectal cancer uT3 or uT4
• no distant metastasis
• neoadjuvant radiochemotherapy required

Exclusion Criteria

• rejection of radiochemotherapy

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

St. Claraspital, Chirurgische Klinik; 🇨🇭 Basel, Switzerland